To our knowledge, this is the first investigation that has investigated the relationship of serum MPO concentrations to cardiovascular mortality and lung function decline over 11 years in a very large cohort of COPD patients with mild to moderate airflow limitation. This evidence concerns the gene MPO and chronic obstructive pulmonary disease.